公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
Procleix Reagent Equilibration System80134860295GRIFOLS BRASIL LTDAI现有
Procleix Ultrio Elite Assay Calibrators80134860317GRIFOLS BRASIL LTDAIV07/07/2035
Procleix UltrioPlex E Assay80134860306GRIFOLS BRASIL LTDAIV19/02/2034
Procleix Zika Vírus80134860266GRIFOLS BRASIL LTDAIV30/09/2029
Reverse-Cyte 0.8%80134860269GRIFOLS BRASIL LTDAIV25/11/2029
SERASCAN DIANA 210364120066GRIFOLS BRASIL LTDAIII10/06/2027
SERASCAN DIANA 2P10364120059GRIFOLS BRASIL LTDAIII10/06/2027
SERASCAN DIANA 380134860103GRIFOLS BRASIL LTDAIII09/04/2027
SERASCAN DIANA 3P80134860104GRIFOLS BRASIL LTDAIII23/04/2027
SERASCAN DIANA 410364120060GRIFOLS BRASIL LTDAIII10/06/2027
SERASCAN DIANA 4P10364120062GRIFOLS BRASIL LTDAIII10/06/2027
SERASCAN DIANA DIA80134860123GRIFOLS BRASIL LTDAIII28/09/2034
SERIGRUP DIANA 480134860102GRIFOLS BRASIL LTDAIV09/04/2027
SERIGRUP DIANA A1/B80134860084GRIFOLS BRASIL LTDAIV28/12/2034
SERIGRUP DIANA A280134860105GRIFOLS BRASIL LTDAIV23/04/2027
Screen-Cyte Dia 3%80134860297GRIFOLS BRASIL LTDAIII23/10/2033
Screen-Cyte P 0.8%80134860274GRIFOLS BRASIL LTDAIII22/03/2031
Sero-Cyte 3%80134860299GRIFOLS BRASIL LTDAIII23/10/2033
Sero-Cyte Pool 0,8%80134860209GRIFOLS BRASIL LTDAIII29/06/2035
Sero-Cyte Pool Diª 0.8%80134860291GRIFOLS BRASIL LTDAIII26/06/2033
Specific Albumin 22%80134860286GRIFOLS BRASIL LTDAI现有
SysCheck80134860309GRIFOLS BRASIL LTDAI现有
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay80134860319GRIFOLS BRASIL LTDAIV28/07/2035
VARIOTIP PREMIUM URETERAL CATHETER80134860164GRIFOLS BRASIL LTDAI现有
WELD B GRIFOLS80134860133GRIFOLS BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家